The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence

被引:72
作者
Purdie, KJ
Pennington, J
Proby, CM
Khalaf, S
de Villiers, EM
Leigh, IM
Storey, A
机构
[1] Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Ctr Cutaneous Res, Imperial Canc Res Fund,Skin Tumour Lab, London E1 2AT, England
[2] Deutsch Krebsforschungszentrum, Div Tumor Virus Characterisat, D-69120 Heidelberg, Germany
关键词
HPV; immunosuppression; p53; skin cancer; UV;
D O I
10.1093/emboj/18.19.5359
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
An aetiological role has been proposed for human papillomavirus (HPV) in skin carcinogenesis within the immunosuppressed patient population, To examine this possibility, we have focused on an HPV type that, to date, has been identified only in the cutaneous lesions of renal transplant recipients despite a high degree of sequence homology with other HPVs commonly found in warts in the general population. We report that the non-coding region of this virus, HPV type 77, contains a consensus binding site for the tumour suppressor protein p53, and we show by gel-retardation analysis that this sequence does indeed bind p53, Furthermore, using reporter gene assays, we demonstrate that HPV77 promoter activity is stimulated by UV radiation and that this response is mediated through the p53 binding site. This is the first report of a p53-dependent positive response element within a viral genome. Our results suggest a possible novel mechanism by which specific types of HPV might act as cofactors with UV radiation in cutaneous transformation.
引用
收藏
页码:5359 / 5369
页数:11
相关论文
共 50 条
[11]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[12]  
ELDEIRY WS, 1995, CANCER RES, V55, P2910
[13]   HUMAN PAPILLOMAVIRUS TYPE-29 (HPV-29), AN HPV TYPE CROSS-HYBRIDIZING WITH HPV-2 AND WITH HPV-3-RELATED TYPES [J].
FAVRE, M ;
CROISSANT, O ;
ORTH, G .
JOURNAL OF VIROLOGY, 1989, 63 (11) :4906-4906
[14]  
Friedlander P, 1996, MOL CELL BIOL, V16, P4961
[15]   Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein [J].
Funk, JO ;
Waga, S ;
Harry, JB ;
Espling, E ;
Stillman, B ;
Galloway, DA .
GENES & DEVELOPMENT, 1997, 11 (16) :2090-2100
[16]   P53 AND SP1 INTERACT AND COOPERATE IN THE TUMOR NECROSIS FACTOR-INDUCED TRANSCRIPTIONAL ACTIVATION OF THE HIV-1 LONG TERMINAL REPEAT [J].
GUALBERTO, A ;
BALDWIN, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19680-19683
[17]  
HAUSEN HZ, 1989, CANCER RES, V49, P4677
[18]   REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53 [J].
HUPP, TR ;
MEEK, DW ;
MIDGLEY, CA ;
LANE, DP .
CELL, 1992, 71 (05) :875-886
[19]   INVOLVEMENT OF HUMAN PAPILLOMAVIRUS TYPE-8 GENES E6 AND E7 IN TRANSFORMATION AND REPLICATION [J].
IFTNER, T ;
BIERFELDER, S ;
CSAPO, Z ;
PFISTER, H .
JOURNAL OF VIROLOGY, 1988, 62 (10) :3655-3661
[20]   ONCOGENIC FORMS OF P53 INHIBIT P53-REGULATED GENE-EXPRESSION [J].
KERN, SE ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
SEYMOUR, A ;
KINZLER, KW ;
VOGELSTEIN, B .
SCIENCE, 1992, 256 (5058) :827-830